Oliver Wyman January 30, 2025
Aligning incentives, bolstering investments, and enhancing partnerships are steps pharmaceutical companies can take to develop a resilient healthcare system.
Climate change poses a significant risk to public health globally. In fact, climate-generated natural disasters could lead to 14.5 million additional deaths and $12.5 trillion in economic losses by 2050. Several diseases, including malaria, dengue, asthma, heat-related illnesses, hypertension, stunting, and PTSD could see sizeable increases.
Addressing the looming health crisis requires strong public-private collaboration, innovative funding, and harmonized regulatory frameworks. Speaking with Oliver Wyman’s Terry Stone and Dr. Oliver Eitelwein during the World Economic Forum’s annual meeting in Davos,...
Today's Sponsors
Today's Sponsor